Transport characteristics of the anti-human immunodeficiency virus nucleoside analog, abacavir, into brain and cerebrospinal fluid

Journal of Pharmacology and Experimental Therapeutics

Volumn 298, Issue 3, 2001, Pages 947-953

  Thomas, S A ^a   Bye, A ^b   Segal, M B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NITROBENZYLTHIOINOSINE; NUCLEOSIDE ANALOG;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CONTROLLED STUDY; DRUG BRAIN LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG TRANSPORT; GUINEA PIG; ISOTOPE LABELING; NONHUMAN; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; TRANSPORT KINETICS;

ALGORITHMS; ANIMALS; ANTI-HIV AGENTS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIDEOXYNUCLEOSIDES; GUINEA PIGS; PERFUSION; RNA, VIRAL; ULTRAFILTRATION;

EID: 0034883071     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Differential permeability of cerebral capillary and choroid plexus to lanthanum ion
2. Junctions between intimately apposed cell membranes in the vertebrate brain
3. Exploring how to get at - And eradicate - Hidden HIV
4. The physiology of the choroid plexus
5. 1592U89, a novel carbocyclic nucleoside analog with potent selective anti-human immunodeficiency virus activity
6. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy
7. Nutrient transport systems in dog brain
8. Clinical pharmacokinetics of nucleoside antiretroviral agents
9. Cerebrospinal fluid HIV RNA originates from both local central nervous system and systemic sources
10. Unique intracellular activation of the potent anti-HIV agent 1592U89
11. HIV Infection and dementia
12. The entry of anti-viral and anti-retroviral drugs into the central nervous system
13. +-dependent nucleoside transporter in microglia
14. Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type-1 infected children
15. Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society-USA Panel
16. Safety and pharmacokinetics of abacavir (1592U89) following oral administration of escalating single doses in human immunodeficiency virus type-1 infected adults
17. Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice
18. Protein measurements with the Folin phenol reagent
19. Enantiomeric selectivity of carbovir transport
20. Membrane permeation characteristics of the structurally related anti-HIV agents 1592 and (-)-carbovir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells
21. HIV-associated dementia
22. Does brain penetration of anti-HIV drugs matter?
23. 14C]abacavir, a human immunodeficiency virus type 1 (HIV-1) reverse transcriptase inhibitor, administered in a single oral dose to HIV-1 infected adults: A mass balance
24. Junctions in the meninges and marginal glia
25. Decay characteristics of HIV-1 infected compartments during combination therapy
26. Nucleoside and nucleobase transport in animal cells
27. Early penetration of the blood-brain barrier by HIV
28. Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults
29. Investigation of distribution, transport and uptake of anti-HIV drugs to the central nervous system
30. Cellular and anatomical reservoirs of HIV-1 in patients receiving potent anti-retroviral combination therapy
31. Immunofluorescent labelling of tight junctions in the rat brain and spinal cord
32. CSF levels of antiretroviral medications
33. Identification of a saturable uptake system for deoxyribonucleosides at the blood-brain and blood-cerebrospinal fluid barriers
34. The passage of azidodeoxythymidine into and within the central nervous system: Does it follow the parent compound, thymidine?
35. Saturation kinetics and NBMPR sensitivity of thymidine entry into the central nervous system
36. The transport of the anti-HIV drug, D4T, across the blood-brain and blood-CSF barriers
37. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection
38. Mechanisms of nucleobase transport in rabbit choroid plexus
39. 2.5]enkephalin, across the bloodbrain and the blood-CSF barriers
40. Viral kinetics: Implications for treatment